Skip to Content
Merck
  • Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.

Scientific reports (2015-10-02)
Aritro Nath, Irene Li, Lewis R Roberts, Christina Chan
ABSTRACT

Hepatocellular carcinoma (HCC) is the second-leading cause of cancer-related death worldwide, and the factors influencing HCC progression are poorly understood. Here we reveal that HCC progression via induction of epithelial-mesenchymal transition (EMT) is closely associated with the expression of CD36/fatty acid translocase and elevated free fatty acid (FFA) levels. Although obesity is manifested as elevated FFA levels, the degree of EMT was not associated with the body mass index of the patients, highlighting the specific roles of CD36 and FFA uptake. Treatment of human liver cancer cell lines with FFAs exacerbated the EMT phenotype, whereas chemical inhibition of CD36 mitigated these effects. Furthermore, the Wnt and TGF-β signaling pathways were activated upon FFA treatment, potentially acting as upstream activators of the EMT program. These results provide the first direct evidence associating CD36 and elevated FFAs with HCC progression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium oleate, ≥99%
Roche
Cytotoxicity Detection Kit (LDH), suitable for protein quantification, suitable for cell analysis, detection, sufficient for ≤2,000 tests
Sigma-Aldrich
Oil Red O, certified by the Biological Stain Commission
Sigma-Aldrich
Sodium palmitate, ≥98.5%
Sigma-Aldrich
Linoleic acid sodium salt, ≥98% (GC)
Millipore
Anti-CD36 Antibody, clone SM-phi, clone SM-phi, Chemicon®, from mouse
Sigma-Aldrich
Anti-PORCN Antibody, clone 15G12.1, clone 15G12.1, from mouse